Managing Partner at Vivo Capital · Joined 2016
View Live Interactive Profile →Gaurav Aggarwal is a Managing Partner of Vivo Capital. Vivo's biography states he has been an investor in the life sciences sector for more than twenty years and that he rejoined Vivo as a Managing Partner in April 2024, having previously been a Managing Director from 2016 to 2023 and Chief Investment Officer for the firm's U.S. public investment fund from 2021 to 2023. Before Vivo he was Chief Business Officer of Ocera Therapeutics, Inc. from April 2014 to October 2016, Managing Director of Investor Growth Capital during 2013, and a General Partner at the venture capital fund Panorama Capital, L.P. from August 2006 to December 2012; earlier he was an associate with JPMorgan Partners, LLC. He was quoted as Managing Partner in Vivo's 7 May 2025 announcement of the close of the third cycle of the Vivo Opportunity Fund. No current board seat is recorded: Vivo's biography states he has served on the boards of Unicycive Therapeutics and Geron since March 2023 and November 2023, but Geron's proxy statement filed 7 April 2026 states he resigned from the Geron board effective 10 October 2025 and describes him as a former director, and Unicycive's proxy statement filed 30 April 2026 states he resigned as a director on 6 April 2026. No degree-granting institution is published for him, so education is left empty.